Benjamin Paluch

Stock Analyst at Roth MKM

(1.29)

# 3,673

Out of 5,154 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$61.88	+5.04%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$8.07	+110.66%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.71	+269.00%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $61.88

Upside: +5.04%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $8.07

Upside: +110.66%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.71

Upside: +269.00%